Just as government works with companies in an attempt to convince them of the need for change on rebates, it confronts them with dramatic changes to PBS cost-recovery, developed and presented with no consultation. Hardly an approach to engender trust. …
Latest Video
New Stories
-
A relationship that works for patients
January 18, 2019 - - Comment -
Pharmaxis updates on LOXL2 studies
January 18, 2019 - - Latest News -
Clock ticking as caretaker approaches
January 17, 2019 - - Latest News -
The genesis of the policy that continues to shape PBS discussions
January 17, 2019 - - Latest News -
Takeda rings the bell in New York
January 17, 2019 - - Latest News -
Novo Nordisk's Michala Fischer-Hansen returning to Denmark
January 17, 2019 - - Latest News -
CHF: End cost-offset rule
January 17, 2019 - - Latest News